News

News Archive

Pope Francis welcomes in audience the Fair Play Menarini Award

Pope Francis welcomes in audience the Fair Play Menarini Award

In the year of its 25th anniversary, a delegation of Menarini Fair Play Ambassadors was received in audience by the Holy Father in the Paul VI Audience Hall

VATICAN CITY, December 22nd, 2021 - This morning, in the solemn setting of the Paul VI Audience Hall, a delegation of Fair Play Menarini Ambassadors was received in audience by the Holy...
Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin America and Other Key Countries Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202.5 Million in Future Milestones, Plus Tiered, Double-digit Royalties on Net Sales

Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin...
Menarini Silicon Biosystems announces new DEPArray™ PLUS application to identify mutations in FFPE tissue samples with low tumor cellularity

Menarini Silicon Biosystems announces new DEPArray™ PLUS application to identify mutations in FFPE tissue samples with low tumor cellularity

Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB’s DEPArray technology* to successfully...
Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting

Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting

Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid...
Menarini: a gift to the Misericordia Campo di Marte to give life to their new ‘home’

Menarini: a gift to the Misericordia Campo di Marte to give life to their new ‘home’

Florence, 10th December 2021 - Menarini has chosen to support the historic Misericordia Campo di Marte San Pietro Martire, through a donation towards the building of their new 'home'. It will be a completely eco-sustainable building, close to where their current operations centre is, in Florence’s Quartiere 2, the same area where the multinational pharmaceutical company is based. The construction of the building is already underway and, thanks to this new, over 300 square metre building, the association will soon be able to provide a greater number of services to the public.

Florence, 10th December 2021 - Menarini has chosen to support the historic Misericordia Campo di Marte San Pietro Martire, through a donation towards the building of their new...
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

Florence, Italy and Boston, Mass., December 8, 2021 – the Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the...
12345

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Follow our blog

Discover our stories from all over the world

Read More